文献速递结核与非结核分枝杆菌艾滋病与性传播感染

在中/高结核发病率地区结核病预防性治疗的长期保护效果

Long-Term Protective Effect of Tuberculosis Preventive Therapy in a Medium/High Tuberculosis Incidence Setting.
PubMed 文献 · Clin Infect Dis · 2024-01-01

在巴西里约热内卢州991名参与者中,比较4个月利福平或9个月异烟肼随机分组后长达12年的结核病发病率。总体结核发病率为1.7/1000人年(95%CI 1.01-2.7)。未完成治疗者发病率高于完成者(2.9 vs 1.1/1000人年;IR比2.7)。完成全程预防性治疗在多为HIV未感染人群中提供长期保护。

要点

  • 总体结核发病率为1.7/1000人年(95%CI 1.01-2.7)。
  • 未完成治疗者结核发病率高于完成者(IR比2.7,95%CI 1.0-7.2)。
  • 随机化后28个月内结核发病率高于28至143个月间(IR比3.1,95%CI 1.2-8.2)。

核心结论

  • 在多为HIV未感染人群中,完成全程结核病预防性治疗可提供长期结核保护。

研究设计与样本

  • 对一项结核病预防性治疗试验中991名巴西参与者进行随机分组后长达12年的随访分析,随机接受4个月利福平或9个月异烟肼,研究地点为里约热内卢州,该州2022年结核发病率为68.6/10万人口。

主要发现

  • 总体结核发病率为1.7/1000人年(95%CI 1.01-2.7)。
  • 未完成预防性治疗者结核发病率为2.9/1000人年(95%CI 1.3-5.6),完成者为1.1/1000人年(95%CI 0.4-2.3),IR比为2.7(95%CI 1.0-7.2)。
  • 随机化后28个月内结核发病率为3.5/1000人年(95%CI 1.6-6.6),28至143个月间为1.1/1000人年(95%CI 0.5-2.1),IR比为3.1(95%CI 1.2-8.2)。
  • 治疗未完成是唯一与发生结核相关的变量(aHR 3.2,95%CI 1.1-9.7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The duration of the protective effect of tuberculosis preventive therapy (TPT) is controversial. Some studies have found that the protective effect of TPT is lost after cessation of therapy among people with human immunodeficiency virus (HIV) in settings with very high tuberculosis incidence, but others have found long-term protection in low-incidence settings. METHODS: We estimated the incidence rate (IR) of new tuberculosis disease for up to 12 years after randomization to 4 months of rifampin or 9 months of isoniazid, among 991 Brazilian participants in a TPT trial in the state of Rio de Janeiro, with an incidence of 68.6/100 000 population in 2022. The adjusted hazard ratios (aHRs) of independent variables for incident tuberculosis were calculated. RESULTS: The overall tuberculosis IR was 1.7 (95% confidence interval [CI], 1.01- 2.7) per 1000 person-years (PY). The tuberculosis IR was higher among those who did not complete TPT than in those who did (2.9 [95% CI, 1.3-5.6] vs 1.1 [.4-2.3] per 1000 PY; IR ratio, 2.7 [1.0-7.2]). The tuberculosis IR was higher within 28 months after randomization (IR, 3.5 [95% CI, 1.6-6.6] vs 1.1 [.5-2.1] per 1000 PY between 28 and 143 months; IR ratio, 3.1 [1.2-8.2]). Treatment noncompletion was the only variable associated with incident tuberculosis (aHR, 3.2 [95% CI, 1.1-9.7]). CONCLUSIONS: In a mostly HIV-noninfected population, a complete course of TPT conferred long-term protection against tuberculosis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Teixeira LAA, Santos B, Correia MG, et al. Long-Term Protective Effect of Tuberculosis Preventive Therapy in a Medium/High Tuberculosis Incidence Setting. Clin Infect Dis. 2024. PMID: 38407417. doi:10.1093/cid/ciae101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。